Quick Answer
Outset Medical, Inc. reported Cash and Equivalents of $35.01 million for fiscal year 2025.
Outset Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $35.01M | -71.8% |
| 2024 | $124.01M | +81.0% |
| 2023 | $68.51M | -6.4% |
| 2022 | $73.22M | -59.8% |
| 2021 | $182.35M | -38.2% |
| 2020 | $294.97M | +698.8% |
| 2019 | $36.93M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $36.44M | +9.5% | -7.9% |
| June 30, 2025 | $39.56M | +4.5% | -47.9% |
| March 31, 2025 | $75.93M | +136.0% | -38.8% |
| December 31, 2024 | $124.01M | +81.0% | +272.6% |
| September 30, 2024 | $33.29M | -8.3% | -12.1% |
| June 30, 2024 | $37.86M | +4.0% | +17.7% |
| March 31, 2024 | $32.18M | -11.6% | -53.0% |
| December 31, 2023 | $68.51M | -6.4% | +88.7% |
- Outset Medical, Inc. showed a decrease of -71.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, Outset Medical, Inc.’s cash and equivalents has declined by 5.2% (from $36.93 million to $35.01 million).
- The most recent figure is from Outset Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: